HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dhawan, V. Articles by Eidelberg, D. Search for Related Content PubMed PubMed Citation Articles by Dhawan, V. Articles by Eidelberg, D.

Comparative Analysis of Striatal FDOPA Uptake in Parkinson’s Disease: Ratio Method Versus Graphical Approach

¹ Center for Neuroscience, North Shore-Long Island Jewish Research Institute, Manhasset, New York; and Department of Neurology, North Shore University Hospital and New York University School of Medicine, Manhasset, New York

Striatal-to-occipital ratio (SOR) and influx constant K_i^occ are commonly used as analytic parameters in L-3,4-dihydroxy-6-¹⁸F-fluorophenylalanine (FDOPA) PET studies. Both have been shown to be useful in discriminating Parkinson’s disease (PD) patients from healthy subjects. We evaluated the relative performance of SOR and influx constant (K_i^occ) in the clinical assessment of nigrostriatal dopaminergic function in PD. Methods: Twenty-one parkinsonian patients (Hoehn and Yahr scale I–IV; mean age ± SD, 56 ± 9.2 y) and 11 healthy subjects (mean age, 60 ± 16 y) underwent 3-dimensional dynamic FDOPA scanning from 0 to 100 min. After spatial realignment, PET images at each frame were integrated by summing 4 central striatal slices, and time-activity curves (TACs) were generated after placing a standard set of elliptic regions of interest over striatal and occipital structures. SOR and K_i^occ values for each subject were then computed from TACs at different times using an input function from the occipital cortex. Results: Both SOR and K_i^occ showed significant bilateral decreases in striatal dopamine uptake in the PD group compared with the control group. SOR values estimated for 10-min frames between 65 and 95 min are statistically equivalent in group discrimination. In addition, SOR values in the caudate and putamen correlated strongly with K_i^occ, especially toward the end of the scanning epoch. Both parameters correlated significantly and comparably with Unified Parkinson’s Disease Rating Scale motor scores. Conclusion: These results suggest that SOR determined from a single 10-min scan at 95 min is as accurate as K_i^occ in separating PD patients from healthy subjects and in predicting clinical measures of disease severity.

Key Words: L-3,4-dihydroxy-6-¹⁸F-fluorophenylalanine • PET • ratio method • graphical analysis • Parkinson’s disease

This article has been cited by other articles:

				N. Okamura, V. L. Villemagne, J. Drago, S. Pejoska, R. K. Dhamija, R. S. Mulligan, J. R. Ellis, U. Ackermann, G. O'Keefe, G. Jones, et al. In Vivo Measurement of Vesicular Monoamine Transporter Type 2 Density in Parkinson Disease with 18F-AV-133 J. Nucl. Med., February 1, 2010; 51(2): 223 - 228. [Abstract] [Full Text] [PDF]

				Y. Ma, C. Tang, T. Chaly, P. Greene, R. Breeze, S. Fahn, C. Freed, V. Dhawan, and D. Eidelberg Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes J. Nucl. Med., January 1, 2010; 51(1): 7 - 15. [Abstract] [Full Text] [PDF]

				P. Jokinen, H. Helenius, E. Rauhala, A. Bruck, O. Eskola, and J. O. Rinne Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls J. Nucl. Med., June 1, 2009; 50(6): 893 - 899. [Abstract] [Full Text] [PDF]

				J. L. Eberling, W. J. Jagust, C. W. Christine, P. Starr, P. Larson, K. S. Bankiewicz, and M. J. Aminoff Results from a phase I safety trial of hAADC gene therapy for Parkinson disease Neurology, May 20, 2008; 70(21): 1980 - 1983. [Abstract] [Full Text] [PDF]

				X.-B. Pan, T. G. Wright, F. J. Leong, R. A. McLaughlin, J. M. Declerck, and D. H.S. Silverman Improving Influx Constant and Ratio Estimation in FDOPA Brain PET Analysis for Parkinson's Disease J. Nucl. Med., October 1, 2005; 46(10): 1737 - 1744. [Abstract] [Full Text] [PDF]

				R Hilker, A T Portman, J Voges, M J Staal, L Burghaus, T van Laar, A Koulousakis, R P Maguire, J Pruim, B M de Jong, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1217 - 1221. [Abstract] [Full Text] [PDF]

				B. Ravina, D. Eidelberg, J. E. Ahlskog, R. L. Albin, D. J. Brooks, M. Carbon, V. Dhawan, A. Feigin, S. Fahn, M. Guttman, et al. The role of radiotracer imaging in Parkinson disease Neurology, January 25, 2005; 64(2): 208 - 215. [Abstract] [Full Text] [PDF]

				W.-S. Huang, Y.-H. Chiang, J.-C. Lin, Y.-H. Chou, C.-Y. Cheng, and R.-S. Liu Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson's Disease Patients J. Nucl. Med., July 1, 2003; 44(7): 999 - 1005. [Abstract] [Full Text] [PDF]